Companies must have already received at least one Phase II award, and total contract value cannot exceed $30 million
Unlike the effectiveness only given before injury (prophylactic effect) of the standard cytoprotective agents (for review, see, i.e., [10,11]), BPC 157, in addition to its prophylactic effect, has a strong curative effect given even much later after injury induction, during ischemia as well as during reperfusion (for review, see, i.e., [2,3,4,5,6,7,8])
If you are interested in improving your health and resilience through science-backed natural options, learning about this peptide combination could be a pivotal step
Body Protection Compound